Proceedings: Evaluation of immune status in tumor patients.
D000230:Adenocarcinoma / Q000276:immunology; D000510:Alpha-Globulins / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology; D002283:Carcinoma, Bronchogenic / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002295:Carcinoma, Transitional Cell / Q000276:immunology; D002452:Cell Count; D004591:Electrophoresis, Polyacrylamide Gel; D005354:Fibrosarcoma / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D037102:Lectins; D008080:Liposarcoma / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000510:Alpha-Globulins; D037102:Lectins; D014316:Tritium; D013936:Thymidine